Breast: Page 146

Patients remain confused about breast density
By AuntMinnie.com staff writers
Despite the fact that breast density notification laws have been in effect in some states since 2009, confusion about breast density itself and whether a woman should get supplemental screening persists, according to a study published August 16 in Academic Radiology.
August 20, 2018
2016 09 06 13 31 23 491 Question Mark Blue 400
Breast screening skeptic Welch accused of plagiarism
By Kate Madden Yee
A Dartmouth College investigation found that Dr. H. Gilbert Welch plagiarized material from a colleague in a 2016 study about overdiagnosis in screening mammography that was published in the New England Journal of Medicine, according to university documents and a report published August 20 by STAT and Retraction Watch.
August 20, 2018
2016 08 26 11 32 34 470 Breast Mammo 400
DBT's benefits vary between Europe and the U.S.
By Kate Madden Yee
A new meta-analysis has reaffirmed the value of digital breast tomosynthesis (DBT) for breast screening, with DBT detecting more cancers with fewer recalls. But DBT's effect varied significantly between the U.S. and Europe, according to results published online August 9 in the Journal of the National Cancer Institute.
August 14, 2018
2016 08 18 13 26 22 430 Breast Screening Mammo 400
Ill. enacts breast density reporting law
By AuntMinnie.com staff writers
Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law on August 10, making Illinois the 36th state to mandate reporting of dense breast tissue to patients.
August 13, 2018
Project links state, national mammography data registries
By Kate Madden Yee
Data from the American College of Radiology's National Mammography Database and data from state cancer registries can be successfully linked, which suggests that researchers could get a better sense of the performance of screening mammography, according to a study published online August 9 in the Journal of the American College of Radiology.
August 12, 2018
2018 08 10 21 39 0206 Breast Cancer2 400
Is radiation therapy warranted for DCIS postlumpectomy?
By Kate Madden Yee
Researchers have found that radiation therapy after lumpectomy in women with ductal carcinoma in situ (DCIS) reduces cumulative breast cancer mortality rates by 25%, compared with treatments that do not include radiation. The results were published online August 10 in JAMA Network Open.
August 10, 2018
2016 09 06 13 31 23 491 Question Mark Blue 400
FDA stops Fla. center from performing mammograms
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has ordered a Florida radiology center to stop performing mammograms and notify patients who underwent mammography there between the middle of 2016 and April of this year, according to a report from NBC 6.
August 8, 2018
FDA OKs iCAD's breast density AI software
By AuntMinnie.com staff writers
Computer-aided detection (CAD) developer iCAD has received clearance from the U.S. Food and Drug Administration (FDA) for the latest version of its PowerLook Density Assessment artificial intelligence (AI) software.
August 7, 2018
Ultrasound elastography helps identify invasive breast cancer
By Kate Madden Yee
Ultrasound using a shear-wave elastography technique can help clinicians determine whether biopsy-confirmed ductal carcinoma in situ should be upgraded to invasive ductal carcinoma, according to a study published online August 1 in the Journal of Ultrasound in Medicine.
August 7, 2018
2018 07 27 16 48 4912 Ultrasound Breast 400
Problems persist for breast cancer detection in Morocco
By Rebekah Moan
In advance of ECR 2019's focus on Africa, we have a special report about Morocco. A new evaluation has found the country continues to come up short in terms of breast cancer detection, even though the rate of annual screening coverage achieved was acceptable.
August 6, 2018
2018 08 07 17 07 1374 Morocco Flag Button 400
FDA OKs Cianna's Scout for soft-tissue localization
By AuntMinnie.com staff writers
Breast tumor localization technology provider Cianna Medical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to extend the indication of its Scout reflector to include localization of soft tissue.
August 6, 2018
FES-PET enhances treatment for metastatic breast cancer
By Wayne Forrest
By identifying differences in estrogen receptor expression through PET imaging with the tracer F-18 fluoroestradiol (FES), clinicians can better direct treatment for patients with metastatic breast cancer, according to a Dutch study published in the August issue of the Journal of Nuclear Medicine.
August 6, 2018
2016 10 05 17 45 45 493 Breast Cancer 400
Previous Page
Page 146 of 579
Next Page